Stock listing

TKD Stock Price, News, Filings & Events — Takeda Pharmaceutical Co. Ltd.

Selected listing: TKD · GETTEX · EUR · DE

The TKD:GETTEX listing represents Takeda Pharmaceutical Co. Ltd., a global biopharmaceutical company focused on delivering innovative medicines in areas such as oncology, gastroenterology, and neuroscience. The company is actively involved in research and development, with recent news highlighting advancements in its pipeline and collaborations aimed at enhancing treatment options. Investors can find relevant filings and updates on upcoming events that may impact the company's market position and growth trajectory. Takeda's commitment to addressing unmet medical needs continues to shape its strategic initiatives in the pharmaceutical landscape.

TKD:GETTEXEURDEUpdated July 25, 2026
Takeda Pharmaceutical Co. Ltd. logo
Ticker
TKD:GETTEX
Asset type
Stock
Market cap
$53.62B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Takeda Pharmaceutical Co. Ltd. TKD:GETTEX stock context

The TKD:GETTEX listing represents Takeda Pharmaceutical Co. Ltd., a global biopharmaceutical company focused on delivering innovative medicines in areas such as oncology, gastroenterology, and neuroscience. The company is actively involved in research and development, with recent news highlighting advancements in its pipeline and collaborations aimed at enhancing treatment options. Investors can find relevant filings and updates on upcoming events that may impact the company's market position and growth trajectory. Takeda's commitment to addressing unmet medical needs continues to shape its strategic initiatives in the pharmaceutical landscape.

Research Takeda Pharmaceutical Co. Ltd.

Alternate listings